AAPL319.97-8.24 (-2.51%) ▼|ABBV256.46-3.75 (-1.44%) ▼|ABT108.33-0.46 (-0.42%) ▼|ACN186.72-6.40 (-3.31%) ▼|ADBE266.51-19.24 (-6.73%) ▼|AMAT454.71+18.80 (+4.31%) ▲|AMD477.57+21.41 (+4.69%) ▲|AMGN437.23-6.89 (-1.55%) ▼|AMT175.85-1.90 (-1.07%) ▼|AMZN258.51-0.39 (-0.15%) ▼|AVGO357.90+0.74 (+0.21%) ▲|AXP326.16-3.66 (-1.11%) ▼|BA212.25+1.74 (+0.83%) ▲|BAC62.68-0.04 (-0.06%) ▼|BKNG193.29-1.84 (-0.94%) ▼|BLK1,122.29-3.86 (-0.34%) ▼|BMY66.82-1.27 (-1.87%) ▼|BNY164.84+0.51 (+0.31%) ▲|BRK-B506.03-2.10 (-0.41%) ▼|C137.72-0.42 (-0.30%) ▼|CAT813.94+13.80 (+1.72%) ▲|CL88.77-1.32 (-1.47%) ▼|CMCSA26.49-0.16 (-0.60%) ▼|COF219.60-0.90 (-0.41%) ▼|COP134.26-1.46 (-1.08%) ▼|COST915.74-9.67 (-1.04%) ▼|CRM259.23-5.20 (-1.97%) ▼|CSCO109.20+0.59 (+0.54%) ▲|CVS96.74-0.46 (-0.47%) ▼|CVX208.60-2.72 (-1.29%) ▼|DE693.53-0.88 (-0.13%) ▼|DHR207.66-3.37 (-1.60%) ▼|DIS105.31-1.85 (-1.73%) ▼|DUK120.22-1.18 (-0.97%) ▼|EMR152.82+2.61 (+1.74%) ▲|FDX322.52-1.79 (-0.55%) ▼|GD359.39-6.48 (-1.77%) ▼|GE337.12+3.64 (+1.09%) ▲|GEV941.95+0.11 (+0.01%) ▲|GILD151.00-0.23 (-0.15%) ▼|GM87.76+0.72 (+0.83%) ▲|GOOG335.31-3.77 (-1.11%) ▼|GOOGL338.46-3.80 (-1.11%) ▼|GS1,038.61+0.68 (+0.07%) ▲|HD321.05+2.98 (+0.94%) ▲|HON209.61+1.98 (+0.95%) ▲|IBM234.89+0.18 (+0.08%) ▲|INTC95.80+4.13 (+4.51%) ▲|INTU332.70-11.60 (-3.37%) ▼|ISRG366.70-3.13 (-0.85%) ▼|JNJ275.23-3.20 (-1.15%) ▼|JPM358.64-3.42 (-0.94%) ▼|KO88.07-0.74 (-0.83%) ▼|LIN477.57-4.62 (-0.96%) ▼|LLY1,149.36-10.24 (-0.88%) ▼|LMT525.28-7.67 (-1.44%) ▼|LOW204.45+2.55 (+1.26%) ▲|LRCX307.65+14.99 (+5.12%) ▲|MA579.21-6.50 (-1.11%) ▼|MCD255.69-3.94 (-1.52%) ▼|MDLZ61.28-0.17 (-0.28%) ▼|MDT94.17+1.07 (+1.15%) ▲|META616.77+6.09 (+1.00%) ▲|MMM168.56+0.25 (+0.15%) ▲|MO68.88-0.61 (-0.88%) ▼|MRK150.33-2.01 (-1.32%) ▼|MS217.72+0.57 (+0.26%) ▲|MSFT499.70-10.42 (-2.04%) ▼|MU1,016.59+58.43 (+6.10%) ▲|NEE83.43-0.63 (-0.75%) ▼|NFLX78.25-4.42 (-5.35%) ▼|NKE38.40-0.37 (-0.95%) ▼|NOW141.26-4.33 (-2.97%) ▼|NVDA230.36+1.91 (+0.84%) ▲|ORCL158.78+4.74 (+3.08%) ▲|PEP137.63-0.91 (-0.66%) ▼|PFE28.45-0.36 (-1.25%) ▼|PG146.44-0.48 (-0.33%) ▼|PLTR174.33-8.20 (-4.49%) ▼|PM182.53-3.64 (-1.96%) ▼|QCOM168.74+0.17 (+0.10%) ▲|RTX200.79-1.34 (-0.66%) ▼|SBUX104.47-1.35 (-1.28%) ▼|SCHW109.29-1.09 (-0.99%) ▼|SO88.11-0.66 (-0.74%) ▼|SPG209.44-2.08 (-0.98%) ▼|T25.68-0.51 (-1.95%) ▼|TMO613.78-4.65 (-0.75%) ▼|TMUS181.52-6.50 (-3.46%) ▼|TSLA354.08-22.29 (-5.92%) ▼|TXN258.44+4.61 (+1.82%) ▲|UBER75.76-0.20 (-0.26%) ▼|UNH397.14-3.80 (-0.95%) ▼|UNP289.62+0.47 (+0.16%) ▲|UPS102.29-1.21 (-1.17%) ▼|USB63.37-0.16 (-0.25%) ▼|V375.07-3.68 (-0.97%) ▼|VZ50.14-0.45 (-0.89%) ▼|WFC89.97+0.78 (+0.87%) ▲|WMT107.14-1.28 (-1.18%) ▼|XOM159.47-2.74 (-1.69%) ▼|AAPL319.97-8.24 (-2.51%) ▼|ABBV256.46-3.75 (-1.44%) ▼|ABT108.33-0.46 (-0.42%) ▼|ACN186.72-6.40 (-3.31%) ▼|ADBE266.51-19.24 (-6.73%) ▼|AMAT454.71+18.80 (+4.31%) ▲|AMD477.57+21.41 (+4.69%) ▲|AMGN437.23-6.89 (-1.55%) ▼|AMT175.85-1.90 (-1.07%) ▼|AMZN258.51-0.39 (-0.15%) ▼|AVGO357.90+0.74 (+0.21%) ▲|AXP326.16-3.66 (-1.11%) ▼|BA212.25+1.74 (+0.83%) ▲|BAC62.68-0.04 (-0.06%) ▼|BKNG193.29-1.84 (-0.94%) ▼|BLK1,122.29-3.86 (-0.34%) ▼|BMY66.82-1.27 (-1.87%) ▼|BNY164.84+0.51 (+0.31%) ▲|BRK-B506.03-2.10 (-0.41%) ▼|C137.72-0.42 (-0.30%) ▼|CAT813.94+13.80 (+1.72%) ▲|CL88.77-1.32 (-1.47%) ▼|CMCSA26.49-0.16 (-0.60%) ▼|COF219.60-0.90 (-0.41%) ▼|COP134.26-1.46 (-1.08%) ▼|COST915.74-9.67 (-1.04%) ▼|CRM259.23-5.20 (-1.97%) ▼|CSCO109.20+0.59 (+0.54%) ▲|CVS96.74-0.46 (-0.47%) ▼|CVX208.60-2.72 (-1.29%) ▼|DE693.53-0.88 (-0.13%) ▼|DHR207.66-3.37 (-1.60%) ▼|DIS105.31-1.85 (-1.73%) ▼|DUK120.22-1.18 (-0.97%) ▼|EMR152.82+2.61 (+1.74%) ▲|FDX322.52-1.79 (-0.55%) ▼|GD359.39-6.48 (-1.77%) ▼|GE337.12+3.64 (+1.09%) ▲|GEV941.95+0.11 (+0.01%) ▲|GILD151.00-0.23 (-0.15%) ▼|GM87.76+0.72 (+0.83%) ▲|GOOG335.31-3.77 (-1.11%) ▼|GOOGL338.46-3.80 (-1.11%) ▼|GS1,038.61+0.68 (+0.07%) ▲|HD321.05+2.98 (+0.94%) ▲|HON209.61+1.98 (+0.95%) ▲|IBM234.89+0.18 (+0.08%) ▲|INTC95.80+4.13 (+4.51%) ▲|INTU332.70-11.60 (-3.37%) ▼|ISRG366.70-3.13 (-0.85%) ▼|JNJ275.23-3.20 (-1.15%) ▼|JPM358.64-3.42 (-0.94%) ▼|KO88.07-0.74 (-0.83%) ▼|LIN477.57-4.62 (-0.96%) ▼|LLY1,149.36-10.24 (-0.88%) ▼|LMT525.28-7.67 (-1.44%) ▼|LOW204.45+2.55 (+1.26%) ▲|LRCX307.65+14.99 (+5.12%) ▲|MA579.21-6.50 (-1.11%) ▼|MCD255.69-3.94 (-1.52%) ▼|MDLZ61.28-0.17 (-0.28%) ▼|MDT94.17+1.07 (+1.15%) ▲|META616.77+6.09 (+1.00%) ▲|MMM168.56+0.25 (+0.15%) ▲|MO68.88-0.61 (-0.88%) ▼|MRK150.33-2.01 (-1.32%) ▼|MS217.72+0.57 (+0.26%) ▲|MSFT499.70-10.42 (-2.04%) ▼|MU1,016.59+58.43 (+6.10%) ▲|NEE83.43-0.63 (-0.75%) ▼|NFLX78.25-4.42 (-5.35%) ▼|NKE38.40-0.37 (-0.95%) ▼|NOW141.26-4.33 (-2.97%) ▼|NVDA230.36+1.91 (+0.84%) ▲|ORCL158.78+4.74 (+3.08%) ▲|PEP137.63-0.91 (-0.66%) ▼|PFE28.45-0.36 (-1.25%) ▼|PG146.44-0.48 (-0.33%) ▼|PLTR174.33-8.20 (-4.49%) ▼|PM182.53-3.64 (-1.96%) ▼|QCOM168.74+0.17 (+0.10%) ▲|RTX200.79-1.34 (-0.66%) ▼|SBUX104.47-1.35 (-1.28%) ▼|SCHW109.29-1.09 (-0.99%) ▼|SO88.11-0.66 (-0.74%) ▼|SPG209.44-2.08 (-0.98%) ▼|T25.68-0.51 (-1.95%) ▼|TMO613.78-4.65 (-0.75%) ▼|TMUS181.52-6.50 (-3.46%) ▼|TSLA354.08-22.29 (-5.92%) ▼|TXN258.44+4.61 (+1.82%) ▲|UBER75.76-0.20 (-0.26%) ▼|UNH397.14-3.80 (-0.95%) ▼|UNP289.62+0.47 (+0.16%) ▲|UPS102.29-1.21 (-1.17%) ▼|USB63.37-0.16 (-0.25%) ▼|V375.07-3.68 (-0.97%) ▼|VZ50.14-0.45 (-0.89%) ▼|WFC89.97+0.78 (+0.87%) ▲|WMT107.14-1.28 (-1.18%) ▼|XOM159.47-2.74 (-1.69%) ▼|
19.9 C
New York
Monday, September 7, 2026

Tag: integration

AI-Enabled Drug Discovery and Clinical Trials Research Report 2025-2035 Featuring AiCure, Aitia, Atomwise, BenevolentAI, Insilico Medicine, PathAI, Recursion, Saama, Schroedinger, Tempus, Unlearn.ai

Discover the thriving AI-Enabled Drug Discovery and Clinical Trials Market set to exceed USD 3 billion by 2025, with projections extending to 2035. Key growth drivers include accelerated drug development timelines and cost efficiency through AI innovations such as generative models and predictive analytics. Despite challenges like regulatory compliance and data integration, the report highlights lucrative investment areas and regional market forecasts. Gain insights into market dynamics, competitive landscapes, and strategic opportunities to stay ahead in this evolving industry.
Discover the thriving AI-Enabled Drug Discovery and Clinical Trials Market set to exceed USD 3 billion by 2025, with projections extending to 2035. Key growth drivers include accelerated drug development timelines and cost efficiency through AI innovations such as generative models and predictive analytics. Despite challenges like regulatory compliance and data integration, the report highlights lucrative investment areas and regional market forecasts. Gain insights into market dynamics, competitive landscapes, and strategic opportunities to stay ahead in this evolving industry.

Quality of Sales Framework to be Showcased at ACG Dealfest Northeast on June 11

Ed Marsh and Ben Tagoe will show Private Equity Sponsors how Quality of Sales can help create value faster through organic growth BOSTON, June 9, 2025...

Level2 Partners with Lightspeed to Deliver Intuitive, No-Code Systematic Trading Solutions for Active Traders

LONDON, June 9, 2025 /PRNewswire/ -- Level2 and Lightspeed Financial Services Group LLC are joining forces to empower a new generation of active traders...

Inbound Tourism to “Charm of Jiangsu”: Discover Jiangsu, Understand China

NANJING, China, June 09, 2025 (GLOBE NEWSWIRE) -- Following the "Inbound Tourism Jiangsu: A Meeting with Cultural Exchange" cultural and tourism exchange event held in Nanjing on February 27th, From May 17th to May 21st, the "Charm of Jiangsu" Global Communication Center invited 15 representatives of international travel agencies, overseas social media influencers, and representatives of overseas enterprises in China from countries such as France, Turkey, and Russia to embark on a five-day canal culture and charm journey in central and northern Jiangsu. Along the way, they explored the four distinctive cities of Lianyungang, Huai'an, Yangzhou, and Taizhou in "Charm of Jiangsu", immersing themselves in its beauty to "understand China".

Power Metallic Acquires 167KM² from Li-FT Power, Expanding Nisk – Lion Polymetallic Project Area by over 300%

TORONTO, June 9, 2025 /PRNewswire/ - Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) is pleased to announce it...

Amicomed by Newel Health obtains EU MDR certification as a digital medical device for hypertension management

BASEL, Switzerland and MILAN, June 9, 2025 /PRNewswire/ -- Newel Health, a European HealthTech company specialized in certified digital medical devices, announced today that Amicomed,...

TGS and Oseberg Partner to Integrate Lease Data into Well Data Analytics Platform

HOUSTON, Texas (09 June 2025) – TGS, a global leader in energy data and intelligence, has announced a strategic partnership with Oseberg, a premier provider of lease and regulatory data for the energy sector. This collaboration brings Oseberg lease data attributes into TGS’ Well Data Analytics (WDA) platform for enhanced analysis.

Sungrow Releases the Groundbreaking PowerTitan 3.0 Energy Storage System Platform

The PowerTitan 3.0 Energy Storage System Platform, available in 10ft Flex, 20ft Class, and 30ft Plus versions, supports durations of 2-12 hours.The 30ft PowerTitan 3.0...

Xinhua Silk Road: China Weihai, S. Korea Incheon building up momentum to bolster local cooperation

BEIJING, June 8, 2025 /PRNewswire/ -- As east China's Shandong Weihai and Incheon of South Korea embrace the 10th anniversary of building the local...

SkyCrest Capital Announces Completion of SAX-iCore Upgrade for AI Trading System SkyAlpha X, Secures $150 Million in Institutional Orders

Denver, UT, June 08, 2025 (GLOBE NEWSWIRE) -- SkyCrest Capital officially announced today that its core AI trading system, SkyAlpha X, has successfully completed a comprehensive upgrade to its third-generation architecture, launching the institutional-grade version SAX-iCore (SkyAlpha X Institutional Core). This upgrade marks SkyAlpha X’s entry into a new era that balances high-frequency trading, cross-market arbitrage, and structured asset management, quickly drawing significant attention from international markets.




According to SkyCrest Capital's technical and business teams, SAX-iCore has so far secured procurement intentions and signed orders from global hedge funds, quantitative institutions, and crypto-financial platforms, totaling $150 million. These include:

 • A cross-asset hedge fund based in New York managing over $4.5 billion in assets, which has formally signed an integration agreement to deploy SAX-iCore for strategy automation in the U.S. equities and ETF options markets.

 • A digital asset market maker in Singapore, which has embedded SAX-iCore as the core execution module in its DEX liquidity engine, mainly for perpetual contract arbitrage and volatility trading.

 • An asset management firm in London that has signed a cooperation agreement for the AI-driven options volatility detection module, planning to integrate SAX-iCore into its global macro hedge strategies.

Key highlights of the upgrade include:

 • Structured Volatility Engine (SVE): Detects breakout windows hidden within intraday price behavior, adaptable to index futures, tech stocks, and cryptocurrencies.

 • Cross-Market Signal Coordination System: Enables strategic integration across U.S. equities, crypto, and options markets for trend capture, volatility arbitrage, and macro alerts.

 • Smart Capital Flow Radar (SCF-Radar): Tracks institutional build-up and withdrawal paths to construct real-time capital behavior maps, enhancing trend confirmation efficiency.

 • Options Anomaly Volatility Alert Module: Combines implied volatility shifts with Gamma risk identification to significantly improve strategic responsiveness and defense ahead of market events.




Dr. Ross, Founder and Chief Science Officer of SkyCrest Capital, stated:

"SAX-iCore is not a mere upgrade of a traditional trading system, but a deep response to the increasingly interconnected multi-market environment. We've made breakthroughs not only at the algorithmic level but also ensured the system evolves in sync with real-world trading structures-this enables us to provide institutional investors with faster, more penetrative strategic decision engines amid globally intensifying asset volatility."

Since its initial launch in 2021, SkyAlpha X has delivered structured trading insights for stocks, futures, options, and crypto assets to SkyCrest's strategy teams and institutional partners. As the flagship module of the platform's 3.0 phase, SAX-iCore will serve as the core infrastructure for high-frequency trading, global asset allocation, and AI-driven execution system integration.

SkyCrest Capital is currently offering early access to SAX-iCore for select strategic partners and is opening a whitelist application process for high-net-worth clients to access strategic modules. Retail-focused modules and tiered signal services for high-frequency trading are planned for phased rollout.

For further information, please contact:

Media Contact

SkyCrest Capital PR Department

Website: https://www.skyskinla.com/

Contact: Audrey Sinclair

Email: service@skyskinla.com

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

Bitcoin Solaris Presale Surges Past $3.8M as Final $6 Phase Nears Close

TALLINN, Estonia, June 08, 2025 (GLOBE NEWSWIRE) -- The crypto community is buzzing as Bitcoin Solaris (BTC-S) crosses a major milestone, raising $3.8 million in its ongoing presale. With over 11,000 participants already onboard and the token price still at just $6, this marks one of the most rapid early-stage raises of 2025.

HepatoBurn Announces Official Website Update Featuring Natural Daily Supplement for Metabolic Health and Liver Function

Science-Inspired Supplement Supports Liver Function and Metabolic Health as Part of a Daily Adult Wellness Routine
Science-Inspired Supplement Supports Liver Function and Metabolic Health as Part of a Daily Adult Wellness Routine

Australia Online Casino Trends Reveal Reddit Community Preferences for Real Money Gaming in 2025 By Spinsy Online Casino

Online Casino Australia Platform Analysis: Spinsy's Real Money Gaming Features for 2025
Online Casino Australia Platform Analysis: Spinsy's Real Money Gaming Features for 2025

Bitcoin Solaris Announces Final Day of Phase 6 Presale at $6 per Token

Bitcoin Solaris
TALLINN, Estonia, June 07, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), a next-generation blockchain platform engineered for speed, decentralization, and smart contract utility, today announced the final day of Phase 6 of its presale. Priced at $6 per token, this marks the last opportunity for early supporters to participate before the next price increase to $7, with the public launch set at $20.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsIntegration